Becton, Dickinson and Co. | BDX - Capitale Ordinario





Capitale Ordinario Cambiamento Data
Abbott USD 1.74B 23.39B 2025-09
Agilent USD 282.22M 478K 2026-03
Align Technology USD 71.62M 133K 2026-03
AngioDynamics USD 41.57M 127K 2025-09
Avanos Medical USD 46.67M 216.61K 2026-03
Baxter International USD 516.45M 2.17M 2026-03
Becton, Dickinson and Co. USD 284.91M 1.72M 2025-12
Bio-Rad Laboratories USD 26.99M 18K 2025-12
Boston Scientific USD 1.48B 2.66M 2025-12
Cooper Companies USD 195.11M 14K 2026-03
Danaher USD 707.7M 800K 2026-03
Dentsply International USD 200.3M 700K 2026-03
Dexcom USD 385.9M 1.1M 2026-03
Edwards Lifesciences USD 580.7M 0 2025-12
Globus Medical USD 135.06M 449K 2025-12
Insulet USD 69.26M 1.08M 2026-03
Integra LifeSciences USD 77.82M 69K 2026-03
Intuitive Surgical USD 355.17M 674K 2026-03
J&J USD 2.41B 1.74M 2025-12
Medtronic USD 1.28B 1.38M 2025-12
Solventum Corp USD 173.53M 40.79K 2026-03
Stryker USD 382.98M 584K 2026-03
Tandem Diabetes Care USD 68.29M 518K 2025-12
Teleflex USD 44.26M 70K 2026-03
Terumo JPY 1.48B 11K 2026-03
Thermo Fisher Scientific USD 371.62M 4.09M 2026-03
Zimmer Biomet Holdings USD 195.5M 2.68M 2026-03